Skip to main content

Advertisement

Log in

Catechol-O-methyltransferase (COMT) genetic polymorphism in a Turkish population

  • Short Communication
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract.

Catechol O-methyltransferase (COMT) inactivates neurotransmitters, catechol hormones and drugs such as levodopa and methyldopa. A low activity allele has been demonstrated at codon 108/158 of the soluble and membrane-bound COMT, respectively, whereby a G to A transition results in a valine to methionine substitution. Ethnic and inter-individual differences in red blood cell COMT activity have been observed in the different populations studied so far. Since, no information is available on inter-individual variability of COMT genotype in Turkish population, we genotyped 217 healthy, unrelated Turkish individuals. The allelic frequencies of COMT gene in the Turkish population were found to be the same as has been observed in Caucasians, but different from Orientals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kocabaş, N., Karakaya, A., Cholerton, S. et al. Catechol-O-methyltransferase (COMT) genetic polymorphism in a Turkish population. Arch Toxicol 75, 407–409 (2001). https://doi.org/10.1007/s002040100252

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002040100252

Navigation